Eagle’s Eye View: Can apixaban be used safely in patients with AF and end-stage kidney disease?
Listen now
Description
In this week’s View, Dr. Eagle explores the associations of apixaban dose with safety and effectiveness outcomes in patients with atrial fibrillation and severe chronic kidney disease. He then discusses a study that looks at stroke risk in women with atrial fibrillation. Finally, Dr. Eagle examines the DCM Precision Medicine Study of rare variant genetics and dilated cardiomyopathy severity.   Subscribe to Eagle’s Eye View  
More Episodes
In this week’s View, Dr. Eagle looks at the durability of pulmonary vein isolation using pulsed-field ablation, then examines genetic penetrance of dilated cardiomyopathy in genotype-positive relatives. Finally, Dr. Eagle shares some thoughts on reinterventions after CoreValve/Evolut TAVR or SAVR...
Published 05/01/24
In this week’s View, Dr. Eagle looks at a scientific statement from the American Heart Association on the diagnosis and management of cardiac sarcoidosis. He then examines the temporal trends and clinical implications of ischemic stroke in women with atrial fibrillation. Finally, Dr. Eagle shares...
Published 04/24/24